IMS Health today announced
a major new global strategic
alliance with Quintiles, with the
aim of advancing the use of “next
generation real-world evidence in
late-stage clinical research”.
The collaboration will combine
IMS Health’s strength in
technology-related real world
information management and
advanced commercial and clinical
analytics, with Quintiles’ expertise
in prospective studies and scientific
knowledge to improve the quality
and impact of real-world evidence.
“We are excited to offer an
improved method for generating
healthcare evidence that addresses
a long-standing need for more
robust information, greater insight
on disease and treatment impact,
and more-cost-effective data
collection, said IMS Health’s Jon
Resnick.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Oct 15
NEW data from the Australian Institute of Health and Welfare has revealed around 43% (or 8.5 million) of Australians aged 16-85 have experienced a mental disorder at some point in their lives.
THE Pharmacy Guild of Australia has formally expressed its concerns regarding the potential merger between Sigma and Chemist Warehouse (PD 07 Dec 2023) to the Australian Competition and Consumer Commission (ACCC).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.